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Abstract
Background
Most studies showing a volume outcome effect in resection surgery for oesophago-gastric
cancer were conducted before the centralisation of clinical services. This study evaluated
the relation between hospital- and surgeon volume and different risk-adjusted outcomes
after oesophago-gastric (OG) cancer surgery in England between 2011 and 2013.
Methods
In data from the National Oesophago-Gastric Cancer Audit from the UK, multivariable ran-
dom-effects logistic regression models were used to quantify the effect of surgeon and hos-
pital volume on three outcomes: 30-day and 90-day mortality and anastomotic leakage. The
models included patient risk factors to adjust for differences in case-mix among hospitals
and surgeons. The between-cluster heterogeneity was estimated with the median odds ratio
(MOR).
Results
The study included patients treated at 42 hospitals and 329 surgeons. The median (inter-
quartile range) of the annual hospital and surgeon volumes were 110 patients (82 to 137)
and 13 patients (8 to 19), respectively. The overall rates for 30-day and 90-day mortality
were 2.3% and 4.4% respectively, and the anastomotic leakage was 6.3%. Higher hospital
volume was associated with lower 30-day mortality (OR: 0.94; 95% CI: 0.91–0.98) and
lower anastomotic leakage rates (OR: 0.96; 95% CI: 0.93–0.98) but not 90-day mortality.
Higher surgeon volume was only associated with lower anastomotic leakage rates (OR:
0.81; 95% CI: 0.72–0.92). Hospital volume explained a part of the between-hospital
PLOS ONE | https://doi.org/10.1371/journal.pone.0183955 October 26, 2017 1 / 11
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPENACCESS
Citation: Fischer C, Lingsma H, Klazinga N,
Hardwick R, Cromwell D, Steyerberg E, et al.
(2017) Volume-outcome revisited: The effect of
hospital and surgeon volumes on multiple outcome
measures in oesophago-gastric cancer surgery.
PLoS ONE 12(10): e0183955. https://doi.org/
10.1371/journal.pone.0183955
Editor: Zachary A. Smith, Northwestern University,
UNITED STATES
Received: August 10, 2016
Accepted: August 15, 2017
Published: October 26, 2017
Copyright: © 2017 Fischer et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: The clinical data used
in this study was third party data collected as part
of the National Oesophago-Gastric Cancer Audit,
which is commissioned by the Healthcare Quality
Improvement Partnership (HQIP). HQIP is the data
controller for this dataset and access to the data is
subject to a Data Sharing Agreement and copyright
license. Interested parties are able to obtain the
clinical audit data directly from HQIP via their Data
Access Request process. This process is described
on the HQIP website (http://www.hqip.org.uk/
variation in 30-day mortality whereas surgeon volume explained part of the between-hospi-
tal variation in anastomotic leakage.
Conclusions
In the setting of centralized O-G cancer surgery in England, we could still observe an effect
of volume on short-term outcomes. However, the effect is inconsistent, depending on the
type of outcome measure under consideration, and much smaller than in previous studies.
Efforts to centralise O-G cancer services further should carefully address the effects of both
hospital and surgeon volume on the range of outcome measures that are relevant to
patients.
Introduction
For many surgical procedures, patient outcomes have been found to be related to surgical vol-
ume (the number of procedures that is performed in a specific unit), with studies typically
showing that higher volumes are associated with lower postoperative mortality [1]. As a result,
the centralization of high-risk oncological services, including oesophago-gastric cancer (O-G
cancer), is occurring in many countries [2–6]. In the UK, the Department of Health published
a recommendation to centralize curative surgical services into specialised cancer centres in
2001 [7]- and it is recommended that surgeons perform a minimum of 15–20 annual resec-
tions[8]. As a consequence, a process of reorganization has taken place in the National Health
Services (NHS) during the past decade, which has resulted in a smaller number of acute trusts
(hospital organisations) doing this type of surgery.
In O-G cancer surgery, risk-adjusted postoperative mortality and complication rates are
widely used as quality indicators[9]. Case volume has also been proposed as a marker for qual-
ity in the past because of the substantial evidence of a volume-outcome relationship[10]. How-
ever, it is unclear whether a volume-outcome relationship is still detectable given that, in a
centralized setting, all trusts may exceed recommended thresholds. In addition, the exact
mechanism behind the volume-outcome relation is still not fully understood[11,12]. It is sug-
gested that both the experience of the surgeon and the complete hospital team contribute to
surgical outcomes[10]. Finally, there are more outcomes of interest for O-G cancer surgery
than the commonly used 30-day mortality. Recent publications suggest that anastomotic leak-
age rates and 90-day postoperative mortality are also important in assessing the quality of sur-
gical care [13–17].
This study was undertaken to examine the relation between hospital- and surgeon volume
and different risk-adjusted outcomes after O-G cancer surgery in a setting of centralized care,
and the between-hospital and surgeon differences in outcome.
Methods
Data
We used data submitted to the National Oesophago-Gastric Cancer Audit (NOGCA), which
evaluates the care delivered by all (n = 154) English hospitals that provide care to adults diag-
nosed with invasive, epithelial cancer of the oesophagus or stomach. Data are collected pro-
spectively by hospital staff and have been submitted to the audit since 1 April 2011. Details on
the audit method and dataset have previously been published[18]. All patients undergoing
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curative surgery between 1 April 2011and 31 March 2013 were included in the study. The date
of death was obtained from the Office for National Statistics Death Register. We excluded
patient undergoing curative oncological treatment for squamous cell carcinoma and all pallia-
tive patients. Further, we excluded hospitals which operated on less than 10 patients (S1 Fig).
Predictors and outcomes
We considered three outcomes: 30-day mortality, 90-day mortality and anastomotic leakage.
Mortality was defined as all-cause postoperative mortality within 30 or 90 days after surgery.
Anastomotic leakage was defined as severe disruption to the anastomosis, irrespective of
whether detected clinically or radiologically, and irrespective of whether it is managed conser-
vatively or by re-operation[19]
Pre-operative patient and tumour characteristics to be used for case-mix adjustment were
based on prior research. All regression models included: comorbidity count, age, ASA score,
ECOG (WHO) performance status, T stage, N stage, cancer location. Patient gender was also
included in the models for the outcomes 90-day mortality and AL, and deprivation was
included in the AL model. We analysed hospital and surgeon volume. Hospital was defined as
NHS trust, which is a division within the English NHS that can consist of up of up to five hos-
pitals. Usually O-G cancer surgery is only performed in one hospital in the trust. Surgeon was
defined as the principal operating surgeon.
Hospital volume was defined as the number of O-G cancer surgeries performed at a NHS
trust per year. Surgeon volume was defined as the annual number of operations conducted by
an individual surgeon.
Statistical analysis
Patient characteristics were described as means or percentages. We described surgeon and
hospital volume in the study period with median volume per hospital/surgeon. To describe
outcome differences, we divided the hospitals/surgeons in quartiles based on volume and pre-
sented the outcome rates for each volume quartile.
The effect of hospital and surgeon volume on the three patient outcomes was tested in mul-
tivariable case-mix adjusted logistic regression models, with volume added as a continuous
variable. We tested whether the relationship between volume and the outcomes was non-linear
by adding squared terms and comparing these with linear terms based on the chi-square
statistic.
We assessed differences in outcome between hospitals with random effects models[20].
First, we analysed between hospitals and surgeons differences without any adjustment. This
random effects model includes two random intercepts: one for hospital and one for surgeon
and no other covariates. The variance of the random intercepts represents the between hospi-
tal/surgeon variation without any adjustment, but taking into account the random variation.
In the second model the case-mix adjustment variables were added as covariates, to adjust the
between hospital/surgeon variation for differences in patient characteristics. In a next step, we
added surgeon and hospital volume one by one as covariates. In a final step, we included both
surgeon and hospital volume.
In random effects models the between hospital/surgeon variation is reflected in the variance
of the random intercepts (τ2). We used the median odds ratio (MOR) to quantify this varia-
tion. The MOR is a direct function of τ2 (MOR = exp (
p
2 x τ2 x F–1 (0.75)) 21. The MOR can
be equal or greater than 1, an MOR of 1 reflects no variation between the hospitals. The larger
the between-hospital variation, the higher the MOR will be[21].
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There were no missing values in patient outcomes. Missing data in predictors were imputed
using a ‘multiple imputation by chained equations’ model including the outcome measures
and relevant covariates. Imputation and statistical analysis were performed Stata software, ver-
sion 11(StataCorp.2009.Stata Statistical Software: Release: 11) and in R statistical software 2.7.2
using the Hmisc, the lm4 and rms packages (R Foundation for Statistical Computation,
Vienna) Syntax code for R is provided in the appendix (S1 Text).
Results
Descriptives
The study included 4868 patients treated at 42 hospitals and 329 surgeons. Patients had a
mean age of 66 years and the majority were male (n = 3610; 74%). See Table 1 for all patient
characteristics. Overall, 30-day mortality was 2.3% (n = 111), 90-day mortality was 4.4%
(n = 215), and 6.3% (n = 305) of the patients developed an anastomotic leakage (AL).
Variation on surgeon and hospital level. Volume varied between both surgeons and hos-
pitals. The median hospital volume was 55 patients per year, with an interquartile range of 41
and 68 (Fig 1). The median surgeon operated 6 patients per year, and the interquartile range
was 4 and 9 (Fig 1).
The risk of all outcomes was lower in the highest volume quartiles compared to the lowest
volume quartiles (Table 2). For example, 30-day mortality was 3.0% in the lowest hospital vol-
ume quartile compared 1.3% in the highest quartile.
Higher hospital volume was a significant independent predictor for lower 30-day mortality
(OR: 0.94 (95%CI: 0.91–0.98) per increase of 5 patients per year) (Table 3). Surgeon volume
had no significant effect on 30-day mortality. Higher surgeon and higher hospital volume were
independent predictors of lower risk of an anastomotic leakage (hospital volume OR: 0.96
(95%CI: 0.93–0.98), surgeon volume: OR: 0.88 (95% CI: 0.78–1.00). Neither hospital volume
nor surgeon volume were significant predictors for 90-day mortality when controlling for each
other (Table 3).
Hospital volume explained part of the variation in 30-day mortality between the hospitals.
The median odds ratio (MOR) decreased from 1.38 without controlling for hospital volume in
the model to 1.30 when hospital and surgeon volume were added to the models as covariates
(Fig 2). The MOR represents the odds of dead within 30 days of a patient from a randomly
selected hospital compared to the odds if he/she would go to another randomly selected hospi-
tal, after taking into account the random variation and differences in patient characteristics.
Surgeon volume did not explain between-hospital or between-surgeon variation in 30-day
mortality (Fig 2, S1 Table).
Hospital volume explained more of the between-surgeon variation in anastomotic leakages
(change in MOR from 1.67 to 1.56) (Fig 2). The other way around, surgeon volume explained
a very small part of the variation between hospitals (change in MOR from 1.29 to MOR 1.27)
(Fig 2).
While hospital volume explained a minimal amount of between-hospitals variation in
90-day mortality, surgeon volume did not explain any variation in 90-day mortality at all
(Fig 2).
Discussion
Main findings
This study has shown that despite centralization, differences between hospitals and surgeons
in patient outcomes after O-G surgery still exist in England. These between-hospital and
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Table 1. Characteristics of the patients included in the study.
Patient and prognostic information No. of patients %
Age, years 4859 66*
Missing values 9 0.2
Comorbidity count
No comorbidities 2735 56.2
One comorbidity 1309 26.9
Two comorbidities 566 11.6
Three or more comorbidities 258 5.3
Gender
Male 3610 74.2
ECOG (WHO) performance status
Carries out all normal activity 2515 51.7
Restricted but walks/does light work 1550 31.8
Walks, full self-care but no work 526 10.8
Limited self-care—fully disabled 120 2.5
Missing values 157 3.2
Size and/or extent of the primary tumour (T)
No evidence of primary tumour T(0) 202 4.1
Tumour invades lamina propria or submucosa T(1) 927 19.0
Tumour invades muscularis propria T(2) 790 16.2
Tumour invades adventitia T(3) 2318 47.6
Tumour invades adjacent structures T(4) 489 10.0
Missing values 142 2.9
Regional lymph nodes (N)
No regional lymph node metastasis N(0) 2137 43.9
Metastasis in 1 to 2 regional lymph nodes N(1) 1496 30.7
Metastasis in 3 to 6 N(2) 614 12.6
Metastasis in 7 or more N(3) 507 10.4
Missing values 114 2.3
ASA Scale
Normal healthy patient 811 16.7
Mild systemic disease 2498 51.3
Severe systemic disease 1246 25.6
Life-threatening disease/ Moribund patient 60 1.2
Missing values 253 5.2
Cancer location
Squamous cell carcinomas of the oesophagus 491 10.1
Adenocarcinomas of the upper and middle oesophagus 183 3.8
Adenocarcinomas of the lower third of the oesophagus and Siewert type 1 tumours 1904 39.1
Siewert type II and type III tumours 840 17.3
Tumours of the stomach 1450 29.8
Deprivation
1 Least deprived 838 17.2
2 859 17.6
3 844 17.3
4 799 16.4
5 Most deprived 745 15.3
Missing values 783 16.1
*Mean
https://doi.org/10.1371/journal.pone.0183955.t001
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between-surgeon differences are partly explained by surgeon and hospital volume but the vol-
ume outcome relation is different for the different outcomes (30-day and 90-day mortality and
anastomotic leakage). Higher hospital volume was associated with lower 30-day mortality, but
high surgeon volume was not. Neither hospital volume nor surgeon volume affected 90-day
mortality. Higher surgeon and hospital volume were both associated with fewer anastomotic
leakages, but surgeon volume was the stronger predictor.
Volume-outcome relation. Higher volume hospitals have lower 30-day mortality rates; this
in line with earlier research in both O-G cancer and other surgical oncological procedures [3,22].
Despite the centralization that took place in the UK, we still found an effect of volume.
In contrast, we did not find surgeon volume to be a significant predictor of 30-day mortal-
ity. Surgeon volume and hospital volume possibly reflect different aspects of quality of care. It
has been suggested that next to the surgeon skills there are other hospital factors in high vol-
ume hospitals that reduce mortality risk, such as post-operative care, care pathways and multi-
disciplinary team work [23–26]
Surgical volume and hospital volume had only a minor effect on 90-day mortality. Although
still a substantial amount of patients dies between 30- and 90-days after surgery, their death
seems not to be influenced by the surgeon or hospital volume. Previous research showed that
although part of the deaths occurring after 30 days is still related to surgery, and increasing
proportion related to cancer recurrence [14]. Both, higher surgeon and hospital volume
showed to be related to fewer anastomotic leakages, but surgeon volume had a stronger effect.
It can be imagined that anastomotic leakages are closely related to technical surgical skills that
high volume surgeons have better developed.
When calculating surgeon volume for highly complicated but rare procedures, it has been
suggested to count also related procedures[27]. In our study we had no data to take into
account other operations as O-G resections.
Fig 1. ab. Hospital volume (1a), surgeon volume (1b). (1a). Median hospital volume = 55; Interquartile range = 41–68. (1b). Median
surgeon volume = 6; Interquartile range = 4–9.
https://doi.org/10.1371/journal.pone.0183955.g001
Table 2. 30-day, 90-day mortality and anastomotic leakage risk according to quartiles of hospital volume and surgeon volume.
Average hospital volume Average surgeon volume
Total Q 1 Q 2 Q 3 Q 4 Q 1 Q 2 Q 3 Q 4
(0–49) (50–65) (66–91) (92–148) (0–5) (6–9) (10–13) (14–28)
N 1,253 1,148 1,360 1,107 1,144 1,156 1,292 1,169
30-day mortality, % 2.3 3.0 3.1 1.7 1.3 2.4 2.3 2.6 0.7
90-day mortality, % 4.4 5.0 5.0 3.8 3.9 4.5 5.4 4.0 1.4
Anastomotic leakage,% 6.3 7.1 8.9 6.3 2.5 7.9 7.1 4.6 1.3
https://doi.org/10.1371/journal.pone.0183955.t002
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Recommendations. In different countries different volume norms are used, which is the
reflection of mixed scientific evidence. Our findings suggest that further increasing hospital
volumes, and to a lesser extent surgeon volumes, might improve short-term outcomes. How-
ever, on-going centralization might also have negative effects on for example access and equity,
which we did not study.
We studied different outcomes that are used as quality indicators. Anastomotic leakages
(AL) rates were affected by hospital volume. This is in line with previous findings that surgical
complications seem to be a good indicator for surgical quality as they are closely related to the
surgical process and are not so much influenced by patient characteristics[9,28,29]. This
makes AL rates ‘actionable’ hospital quality indicators. Apart from the clinical relevance, the
relatively frequent occurrence makes them attractive as a quality indicator from a statistical
point of view, as rates per hospital can be estimated relatively certain. A large disadvantage of
complications as an outcome indicator is their possibly unclear definition, which may bias
between hospital comparison[30].
Adjusted 30-day mortality differences between hospitals were partly explained by hospital
volume. However, a large disadvantage of this measure is the low event rate. Even in our data
pooled from two years, the absolute numbers of deaths within 30-days per hospital were small
(median absolute number per hospital = 2), which makes the estimates per hospital uncertain
and challenges the comparison between hospitals [31,32].
In that sense 90-day mortality rate is more attractive as more deaths occur. However,
90-day mortality differences between hospitals were not explained by hospital volume. Possibly
the 90-day mortality rates might reflect aspects of quality of care not related to volume. But we
consider it is more likely that a longer time period introduces effects of confounding factors
that dilute the relation between quality of care and outcome. In all, multiple indicators should
be monitored as this gives a more comprehensive picture [33].
Next to variation between hospitals, we did observe variation in outcome between surgeons.
But these were not explained by any of the volume indicators. In addition, the absolute num-
bers of deaths of ALs per surgeon are extremely low, which makes outcome rates per surgeon
unsuitable as quality indicators: the difference between 0 or 1 death per year cannot tell us any-
thing about quality, only about bad luck.
In summary, in the setting of centralized O-G cancer surgery in England, we could still
observe an effect of hospitals volume on 30-day mortality and AL rates, suggesting that further
centralization might be considered but should carefully address the effects of both hospital and
surgeon volume on the range of outcome measures that are relevant to patients. AL rates and
Table 3. Association between adjusted volume predictors and the outcomes 30-day mortality, 90-day mortality and anastomotic leakage.
30-day
mortality
90-day mortality Anastomotic leakage
OR 95%CI OR 95%CI OR 95%CI
Surgeon volume*
Adjusted for case-mix 1.03 0.84–1.25 1.01 0.87–1.16 0.88 0.78–1.00
Adjusted for case-mix and hospital volume 0.92 0.76–1.12 0.97 0.85–1.11 0.81 0.72–0.92
Hospital volume*
Adjusted for case-mix 0.94 0.91–0.98 0.98 0.96–1.00 0.95 0.93–0.97
Adjusted for case-mix and surgeon volume 0.94 0.91–0.98 0.98 0.96–1.01 0.96 0.93–0.98
* ORs represent the effect of 5 extra patients per year
https://doi.org/10.1371/journal.pone.0183955.t003
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Fig 2. Change in median odds ratio (MOR) on surgeon level considering different case mix and
prediction factors for 30-day, 90-day mortality and anastomotic leakage. Fig 2 a. Between-hospital
variation in outcomes. Change in median odds ratio (MOR) on hospital level considering different case mix
and prediction factors for 30-day, 90-day mortality and anastomotic leakage. Fig 2 b. Between-surgeon
variation in outcomes. Change in median odds ratio (MOR) on surgeon level considering different case mix
and prediction factors for 30-day, 90-day mortality and anastomotic leakage.
https://doi.org/10.1371/journal.pone.0183955.g002
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30-day mortality rates per hospital could be useful as quality indicators, but both have also dis-
advantages. 90-day mortality likely reflects other things than the quality of surgery and thus is
less suitable as a quality indicator. Surgeon level outcomes are so infrequent that they are not
suitable as quality indicators.
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